Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Firefly NeuroscienceAIFF +7.14%9 EV-to-EBITDA is -2.02 as of Aug. 09, 2026. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review. Among 1,957 Software companies, Firefly Neuroscience ranks worse than 51098.57% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Firefly Neuroscience's enterprise value is $17.61 Mil.
Firefly Neuroscience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.72 Mil. Therefore, Firefly Neuroscience's EV-to-EBITDA for today is -2.02.
The historical rank and industry rank for Firefly Neuroscience's EV-to-EBITDA or its related term are showing as below:
AIFF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -11.63 Med: -1.71 Max: -0.34
Current: -2.02
During the past 5 years, the highest EV-to-EBITDA of Firefly Neuroscience was -0.34. The lowest was -11.63. And the median was -1.71.
AIFF's EV-to-EBITDA is ranked worse than 100% of 1957
companies
in the Software industry
Industry Median: 10.48
vs AIFF: -2.02
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Firefly Neuroscience's PE Ratio (TTM) for today is calculated as:
Firefly Neuroscience's share price for today is $1.20.
Firefly Neuroscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.630.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Firefly Neuroscience's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Firefly Neuroscience's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Firefly Neuroscience EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Firefly Neuroscience's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Firefly Neuroscience's EV-to-EBITDA falls into.
Firefly Neuroscience's current Enterprise Value is $17.61 Mil.
Firefly Neuroscience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Firefly Neuroscience (AIFF) has a EV-to-EBITDA of -2.02 as of Aug. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Firefly Neuroscience. According to the industry distribution chart, Firefly Neuroscience ranks #999999 out of 1957 companies in the Software industry.
Is Firefly Neuroscience's EV-to-EBITDA too high?
Firefly Neuroscience's current EV-to-EBITDA is -2.02. Based on the distribution chart, Firefly Neuroscience ranks #999999 out of 1957 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's EV-to-EBITDA compare to TRSO and FALC?
According to the Software industry distribution chart, Firefly Neuroscience ranks #999999 out of 1957 companies for EV-to-EBITDA. This places Firefly Neuroscience in the lower half of its industry. The industry median EV-to-EBITDA is 10.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.48, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Firefly Neuroscience. For the Software industry, the median EV-to-EBITDA is 10.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current EV-to-EBITDA is -2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current EV-to-EBITDA of -2.02. The current EV-to-EBITDA is -2.02. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current EV-to-EBITDA is -2.02 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score
Get the complete analysis for AIFF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIFF has been successfully added to your 
